• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SURESCAN; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SURESCAN; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR Back to Search Results
Model Number 97712
Device Problems Charging Problem (2892); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Fluid Discharge (2686)
Event Date 06/20/2016
Event Type  Injury  
Manufacturer Narrative
Concomitant medical devices: product id: 977a160, serial# (b)(4), implanted: (b)(6) 2016, explanted: (b)(6) 2016, product type: lead.Product id: 977a160, serial# (b)(4), implanted: (b)(6) 2016, explanted: (b)(6) 2016, product type: lead.
 
Event Description
The healthcare professional (hcp) of a clinical study reported that there was wound dehiscence at the stimulator site.There was implantable neurostimulator (ins) wound site dehiscence and oozing yellow drainage.The wound was opened and the ins was exposed.The patient was sent to the local er for possible infection.An examination showed stimulator site wound dehiscence and infection.Interventions included explanting and replacing the system.The event resulted in in-patient hospitalization and an emergency room visit.The etiology was reported as related to the device or therapy and not related to the implant procedure.The etiology was reported as related to the implantable neurostimulator (ins) pocket.The outcome was resolved without sequelae.Relevant medical history included: non-malignant pain.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from the healthcare professional (hcp) of a clinical study reported that the outcome was resolved without sequelae.There was stimulator site wound dehiscence.
 
Manufacturer Narrative
Device received for analysis which had not yet begun.
 
Event Description
Additional information received reported the device was returned for analysis.
 
Manufacturer Narrative
Analysis of the implantable neurostimulator (ins) showed no significant anomaly.The implantable neurostimulator (ins) was funct ionally okay with insignificant anomalies.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the healthcare professional of the clinical study.Prior to explant, the patient had gone through two rechargers and was still having problems with them on (b)(6) 2016.It was possibly related to the device or therapy (specifically the patient's usability issues) and not related to the implant procedure.No action was taken and there were no further reports of the charger issues before the explant that occurred on (b)(6) 2016.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
H3: see regulatory report #3004209178-2016-14207 for device analysis.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received on 2023-07-07 reporting that the relationship of the event was not related to the device or therapy but was related to the implant procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURESCAN
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key5793974
MDR Text Key49522326
Report Number3004209178-2016-14207
Device Sequence Number1
Product Code GZB
UDI-Device Identifier00643169109506
UDI-Public00643169109506
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P840001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 07/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Model Number97712
Device Catalogue Number97712
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2016
Initial Date Manufacturer Received 06/22/2016
Initial Date FDA Received07/14/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Not provided
06/23/2017
06/23/2017
06/23/2017
07/07/2023
Supplement Dates FDA Received08/23/2016
09/21/2016
10/31/2016
06/09/2017
06/29/2017
07/14/2017
09/24/2017
09/25/2017
07/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient SexFemale
Patient Weight86 KG
-
-